178 related articles for article (PubMed ID: 23826209)
1. Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer.
Lin CM; Fang CL; Hseu YC; Chen CL; Wang JW; Hsu SL; Tu MD; Hung ST; Tai C; Uen YH; Lin KY
PLoS One; 2013; 8(6):e67128. PubMed ID: 23826209
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
Fang CL; Hseu YC; Lin YF; Hung ST; Tai C; Uen YH; Lin KY
PLoS One; 2012; 7(12):e52804. PubMed ID: 23285187
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
4. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma.
Wang C; Zhao H; Lu J; Yin J; Zang L; Song N; Dong R; Wu T; Du X
Diagn Pathol; 2012 Apr; 7():41. PubMed ID: 22510499
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of nuclear protein kinase CK2 Beta subunit and prognosis in human gastric carcinoma.
Lin KY; Fang CL; Chen Y; Li CF; Chen SH; Kuo CY; Tai C; Uen YH
Ann Surg Oncol; 2010 Jun; 17(6):1695-702. PubMed ID: 20087779
[TBL] [Abstract][Full Text] [Related]
7. High expression of mitochondrial intermembrane chaperone TIMM9 represents a negative prognostic marker in gastric cancer.
Lin CC; Fang CL; Sun DP; Hseu YC; Uen YH; Lin KY; Lin YC
J Formos Med Assoc; 2017 Jun; 116(6):476-483. PubMed ID: 27720672
[TBL] [Abstract][Full Text] [Related]
8. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.
Wang L; Zhang J; Yang X; Chang YW; Qi M; Zhou Z; Zhang J; Han B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):301-7. PubMed ID: 23917306
[TBL] [Abstract][Full Text] [Related]
9. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion.
Jafarnejad SM; Wani AA; Martinka M; Li G
Am J Pathol; 2010 Dec; 177(6):2741-52. PubMed ID: 20952589
[TBL] [Abstract][Full Text] [Related]
11. [Expression of transcription factor SOX4 and its clinical significance in female lung cancer patients in Xuanwei area, Yunnan Province].
Zhou YC; Wang XC; Chen Y; Zhang LJ; Liu X; Yao Q; Chen XQ; Zhao GQ; Huang YC
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):202-6. PubMed ID: 23880001
[TBL] [Abstract][Full Text] [Related]
12. High NUSAP1 expression predicts poor prognosis in colon cancer.
Liu Z; Guan C; Lu C; Liu Y; Ni R; Xiao M; Bian Z
Pathol Res Pract; 2018 Jul; 214(7):968-973. PubMed ID: 29853313
[TBL] [Abstract][Full Text] [Related]
13. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
[TBL] [Abstract][Full Text] [Related]
14. FRZB up-regulation is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis.
Shen Y; Zhang F; Lan H; Chen K; Zhang Q; Xie G; Teng L; Jin K
Int J Clin Exp Pathol; 2015; 8(4):4083-90. PubMed ID: 26097596
[TBL] [Abstract][Full Text] [Related]
15. COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis.
Liu F; Ye P; Bi T; Teng L; Xiang C; Wang H; Li Y; Jin K; Mou X
Hepatogastroenterology; 2014 May; 61(131):652-9. PubMed ID: 26176052
[TBL] [Abstract][Full Text] [Related]
16. SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis.
Chen J; Ju HL; Yuan XY; Wang TJ; Lai BQ
Clin Transl Oncol; 2016 Jan; 18(1):65-72. PubMed ID: 26250764
[TBL] [Abstract][Full Text] [Related]
17. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
18. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
19. Period 1 and estrogen receptor-beta are downregulated in Chinese colon cancers.
Wang Y; Xing T; Huang L; Song G; Sun X; Zhong L; Fan J; Yan D; Zhou C; Cui F; Yu F; Chen J; Yu Y; Li C; Tang H; Peng Z; Wang X
Int J Clin Exp Pathol; 2015; 8(7):8178-88. PubMed ID: 26339386
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
